Botox started as therapeutic and got reclassified as cosmetic, but a doctor still has to inject it
The Phase 2/3 LIFT-AD trial (NCT04488419), evaluating once-daily subcutaneous fosgonimeton 40 mg versus placebo in 312 participants with mild-to-moderate Alzheimers disease over 26 weeks, failed its primary endpoint (Global Statistical Test composite of ADAS-Cog11 and ADCS-ADL23) and its key secondary endpoints when results were announced in September 2024
Such closure, paradoxically, opens up the regenerative potential of peri-urban spaces, envisioning eco-public networks at a metropolitan scale as incubators for new urban civic spaces (Formato, 2021) and spatial assemblages capable of recovering living uses (Capone, 2016: 621)
This solution is not intended for human or animal use , clinical application, diagnostic procedures, or therapeutic purposes
It is also described in mechanistic contexts involving nitric oxiderelated pathways, growth factor expression, and cellular processes tied to migration and adhesionconcepts often studied when researchers are investigating how tissues respond and reorganize after experimental injury or stress